Effects of estrogen receptor α and β on the expression of visfatin and retinol-binding protein 4 in 3T3-L1 adipocytes

International Journal of Molecular Medicine

Volumn 32, Issue 3, 2013, Pages 723-728

  Jung, Un Suk ^a   Jeong, Kang Jin ^b   Kang, Jae Ku ^b   Yi, Kyongwook ^c   Shin, Jung Ho ^c   Seo, Hong Seog ^c   Kim, Tak ^c   Kim, Sun Haeng ^c   Hur, Jun Young ^c  

^a Konyang University College of Medicine   (South Korea)

^b Konyang University   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Adipocytes; Adipokines; Retinol binding protein 4; Visfatin

Indexed keywords

1,3 BIS(4 HYDROXYPHENYL) 4 METHYL 5 [4 (2 PIPERIDINYLETHOXY)PHENOL] 1H PYRAZOLE DIHYDROCHLORIDE; 1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ADIPOCYTOKINE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PIPERIDINE DERIVATIVE; PROPIONITRILE; RETINOL BINDING PROTEIN 4; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION; MICE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RETINOL-BINDING PROTEINS, PLASMA;

EID: 84880429728     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1440     Document Type: Article

References (33)

1. Yang Q, Graham TE, Mody N, et al: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362, 2005.
2. Fukuhara A, Matsuda M, Nishizawa M, et al: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426-430, 2005.
3. Klein J, Perwitz N, Kraus D and Fasshauer M: Adipose tissue as source and target for novel therapies. Trends Endocrinol Metab 17: 26-32, 2006.
4. Filippatos TD, Derdemezis CS, Kiortsis DN, Tselepis AD and Elisaf MS: Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome. J Endocrinol Invest 30: 323-326, 2007.
5. Tilg H and Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783, 2006.
6. Masaki T, Anan F, Tsubone T, et al: Retinol binding protein 4 concentrations are influenced by renal function in patients with type 2 diabetes mellitus. Metabolism 57: 1340-1344, 2008.
7. Wajchenberg BL: Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697-738, 2000.
8. Bjorntorp P: Adipose tissue distribution and function. Int J Obes 15 (Suppl 2): 67-81, 1991.
9. Tchernof A and Poehlman ET: Effects of the menopause transition on body fatness and body fat distribution. Obes Res 6: 246-254, 1998.
10. Carr MC: The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88: 2404-2411, 2003.
11. Tchernof A, Desmeules A, Richard C, et al: Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab 89: 3425-3430, 2004.
12. Mizutani T, Nishikawa Y, Adachi H, et al: Identification of estrogen receptor in human adipose tissue and adipocytes. J Clin Endocrinol Metab 78: 950-954, 1994.
13. Kuiper GG, Carlsson B, Grandien K, et al: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870, 1997.
14. Pedersen SB, Bruun JM, Hube F, Kristensen K, Hauner H and Richelsen B: Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol Cell Endocrinol 182: 27-37, 2001.
15. Liu MM, Albanese C, Anderson CM, et al: Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 277: 24353-24360, 2002.
16. Vahlquist A, Rask L, Peterson PA and Berg T: The concentrations of retinol-binding protein, prealbumin, and transferrin in the sera of newly delivered mothers and children of various ages. Scand J Clin Lab Invest 35: 569-575, 1975.
17. Michaelsson G, Vahlquist A, Juhlin L, Mellbin T and Bratt L: Zinc and vitamin A: serum concentrations of zinc and retinol-binding protein (RBP) in healthy adolescents. Scand J Clin Lab Invest 36: 827-832, 1976.
18. Vahlquist A, Johnsson A and Nygren KG: Vitamin A transporting plasma proteins and female sex hormones. Am J Clin Nutr 32: 1433-1438, 1979.
19. Suh JB, Kim SM, Cho GJ, Choi KM, Han JH and Taek Geun H: Elevated serum retinol-binding protein 4 is associated with insulin resistance in older women. Metabolism 59: 118-122, 2010.
20. An C, Wang H, Liu X, et al: Serum retinol-binding protein 4 is elevated and positively associated with insulin resistance in postmenopausal women. Endocr J 56: 987-996, 2009.
21. Kloting N, Graham TE, Berndt J, et al: Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 6: 79-87, 2007.
22. Rodriguez-Cuenca S, Monjo M, Proenza AM and Roca P: Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu. Am J Physiol Endocrinol Metab 288: E200-E207, 2005.
23. Tan BK, Chen J, Lehnert H, Kennedy R and Randeva HS: Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab 92: 2764-2772, 2007.
24. Whitman MM, Harnish DC, Soprano KJ and Soprano DR: Retinol-binding protein mRNA is induced by estrogen in the kidney but not in the liver. J Lipid Res 31: 1483-1490, 1990.
25. Janke J, Engeli S, Boschmann M, et al: Retinol-binding protein 4 in human obesity. Diabetes 55: 2805-2810, 2006.
26. Tschoner A, Sturm W, Engl J, et al: Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity (Silver Spring) 16: 2439-2444, 2008.
27. Matsuda M, Masui F and Mori T: Neonatal estrogenization leads to increased expression of cellular retinol binding protein 2 in the mouse reproductive tract. Cell Tissue Res 316: 131-139, 2004.
28. MacLaren R, Cui W and Cianflone K: Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes. Diabetes Obes Metab 9: 490-497, 2007.
29. Zhou J and Seidel ER: Estrogens induce visfatin expression in 3T3-L1 cells. Peptides 31: 271-274, 2010.
30. Yi KW, Shin JH, Seo HS, et al: Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes. Obesity (Silver Spring) 16: 2393-2399, 2008.
31. Watanobe H and Suda T: A detailed study on the role of sex steroid milieu in determining plasma leptin concentrations in adult male and female rats. Biochem Biophys Res Commun 259: 56-59, 1999.
32. Kristensen K, Pedersen SB and Richelsen B: Regulation of leptin by steroid hormones in rat adipose tissue. Biochem Biophys Res Commun 259: 624-630, 1999.
33. Chen YH, Lee MJ, Chang HH, Hung PF and Kao YH: 17 beta-estradiol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor, extracellularly regulated kinase, and CCAAT/enhancer binding protein-alpha pathways. Endocrinology 147: 4496-4504, 2006.